Thermo Fisher to buy Carlyle-backed PPD for $17.4bn: Bloomberg

Thermo Fisher Scientific Inc. has agreed to acquire PPD Inc, a provider of clinical and research services to the pharma and biotech industries, for $17.4 billion, reported Bloomberg.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this